News and Analysis

EQRx racks up $200 mln Series A

EQRx, a Cambridge, Massachusetts-based drug company, has raised $200 million in Series A funding.

-

EQRx, a Cambridge, Massachusetts-based drug company, has raised $200 million in Series A funding. The investors included GV, ARCH Venture Partners, Andreessen Horowitz, Casdin Capital, Section 32, Nextech and Arboretum Ventures.

Source: Press Release